Philip Watson Mb MSc Frcp Ffpm
About Philip Watson Mb MSc Frcp Ffpm
Philip Watson is an Executive Director at BeiGene with over 20 years of experience in clinical research, specializing in Clinical Development, Pharmacovigilance, and Safety Risk Management.
Current Roles at BeiGene
Philip Watson currently serves as Executive Director at BeiGene in Basel, Basel-Town, Switzerland. His responsibilities include overseeing various executive functions within the company. Additionally, he holds the role of Senior Director at the same company, contributing to the strategic direction and operational efficiency. BeiGene is a global biotechnology company focused on molecularly targeted and immuno-oncology drug development.
Previous Experience at Mediacta PV Ltd
From 2016 to 2019, Philip Watson worked at Mediacta PV Ltd as Director. Based in London, United Kingdom, during his tenure, he was responsible for leading the organization, focusing on pharmacovigilance and safety operations, providing oversight on multiple projects aimed at enhancing patient safety and drug efficacy.
Roles at Roche Products Ltd
Philip Watson has held multiple positions at Roche Products Ltd in Welwyn Garden City, UK. From 2010 to 2013, he served as Global Head, Safety Operations Physicians, and from 2009 to 2010 as Associate Safety Head. He also worked as Senior Drug Safety Physician from 2006 to 2009. In these roles, he managed drug safety teams, ensured compliance with regulatory standards, and contributed to global pharmacovigilance efforts.
Educational Background
Philip Watson studied Medicine at St Mary's Hospital Medical School, Imperial College, London, earning his MBBS degree from 1981 to 1986. He also holds a Master's degree in Medical Informatics. His academic background laid a strong foundation for his career in clinical research, drug safety, and regulatory affairs.
Professional Affiliations and Recognitions
Philip Watson is a registered member of the General Medical Council (GMC) and has been granted Fellowship by The Royal College of Physicians (FRCP) and the Faculty of Pharmaceutical Medicine (FFPM). These affiliations recognize his extensive expertise and contributions to the field of medicine and pharmaceutical practices.